FDA Approval and Acquisitions Propel Syngene’s Growth Amidst Stellar Q1
Healthcare industry leader, Syngene International Limited, is demonstrating not just robust growth but also strategic advancement. Achieving a 26% YoY increase in both revenues and profit after tax, Syngene’s financial…